Ritedose, owned by AGIC and Humanwell, readies William Blair sale process

Less than four years after buying the pharmaceutical business from Olympus Partners, Ritedose's owners, based in China and Europe, could fetch some $1.5bn in a potential transaction.

BySarah Pringle

5 July 2021•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Featured Top Stories

Ritedose, owned by AGIC and Humanwell, readies William Blair sale process

AGIC Group

Olympus Partners

Related articles